Lozada Urbano, Michelle FátimaEspejo Jesus, Melisa Janet2021-03-222021-03-222020-09-10https://hdl.handle.net/20.500.13053/4382An information search was carried out in the databases PUBMED, SCIENCE DIRECT, NCBI, COCHRANE LIBRARY, THE JOURNAL OF PEDIATRICS, finding 43 articles, 10 being selected, which have been evaluated by the CASPE critical reading tool, finally the selected article allowed us to conclude that, when omega-3 fatty acids (DHA and EPA; in a ratio of 3:2 (450-1300 mg / day)) were supplemented during 6 months did not show a significant effect on the reduction of liver fat according to the study. Supplementation with omega-3 showed significant changes in the levels of aspartate aminotransferase (AST) and gamma-glutamyl transpeptidase (GGTP) in children with NAFLD compared to placebo and suggested that omega-3 may be useful in patients. with NAFLD to prevent other complications, such as cardiovascular diseases.Se realizó búsqueda de información en las bases de datos PUBMED, SCIENCE DIRECT, NCBI, COCHRANE LIBRARY, THE JOURNAL OF PEDIATRICS, encontrando 43 artículos, siendo seleccionados 10, los cuales han sido evaluados por la herramienta para lectura crítica CASPE, finalmente el artículo seleccionado permitió concluir que, al suplementarse ácidos grasos omega-3 (DHA y EPA; en una proporción de 3:2 (450-1300 mg / día)) durante 6 meses no evidencio el efecto significativo en la disminución de la grasa hepática según el estudio. La suplementación con omega-3 evidencio en el estudio cambios significativos en los niveles de aspartato aminotransferasa (AST) y gamma-glutamil transpeptidasa (GGTP), en niños con EHGNA en comparación con placebo y sugieren que el omega-3 puede ser útil en pacientes con EHGNA para prevenir otras complicaciones, como enfermedades cardiovasculares.application/pdfspahttp://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-sa/4.0/Enfermedad del Hígado Graso no AlcohólicoRevisiónNiñoNon-alcoholic Fatty Liver DiseaseReviewChildCritical review: effect of omega 3 supplementation in children with nonalcoholic fatty liver disease.Revisão crítica: efeito da suplementação de ômega 3 em crianças com doença fígada gordura não alcoólicaRevisión critíca: efecto de la suplementación de omega 3 en niños con enfermedad del higado graso no alcoholicoCritical review: effect of omega 3 supplementation in children with nonalcoholic fatty liver disease.Revisão crítica: efeito da suplementação de ômega 3 em crianças com doença fígada gordura não alcoólicahttp://purl.org/coar/resource_type/c_7a1fhttps://purl.org/pe-repo/ocde/ford#3.03.04ODS 3: Salud y bienestar. Garantizar una vida sana y promover el bienestar de todos a todas las edades